It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
COVID-19 typically manifests as a respiratory illness, but several clinical reports have described gastrointestinal symptoms. This is particularly true in children in whom gastrointestinal symptoms are frequent and viral shedding outlasts viral clearance from the respiratory system. These observations raise the question of whether the virus can replicate within the stomach. Here we generate gastric organoids from fetal, pediatric, and adult biopsies as in vitro models of SARS-CoV-2 infection. To facilitate infection, we induce reverse polarity in the gastric organoids. We find that the pediatric and late fetal gastric organoids are susceptible to infection with SARS-CoV-2, while viral replication is significantly lower in undifferentiated organoids of early fetal and adult origin. We demonstrate that adult gastric organoids are more susceptible to infection following differentiation. We perform transcriptomic analysis to reveal a moderate innate antiviral response and a lack of differentially expressed genes belonging to the interferon family. Collectively, we show that the virus can efficiently infect the gastric epithelium, suggesting that the stomach might have an active role in fecal-oral SARS-CoV-2 transmission.
Several clinical reports have described gastrointestinal symptoms for COVID-19, though whether the virus can replicate within the stomach remains unclear. Here the authors generate gastric organoids from human biopsies and show that the virus can efficiently infect gastric epithelium, suggesting that the stomach might have an active role in fecal-oral transmission.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details















1 GOS Institute of Child Health, University College London, Stem Cell and Regenerative Medicine Section, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
2 Istituto Zooprofilattico Sperimentale delle Venezie, Lab. of Experimental Animal Models, Division of Comparative Biomedical Sciences, Legnaro, Italy (GRID:grid.419593.3) (ISNI:0000 0004 1805 1826)
3 Veneto Institute of Molecular Medicine (VIMM), Padova, Italy (GRID:grid.428736.c)
4 ShanghaiTech University, Shanghai Institute for Advanced Immunochemical Studies (SIAIS), Shanghai, China (GRID:grid.440637.2) (ISNI:0000 0004 4657 8879)
5 GOS Institute of Child Health, University College London, Stem Cell and Regenerative Medicine Section, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); Veneto Institute of Molecular Medicine (VIMM), Padova, Italy (GRID:grid.428736.c); University of Padova, Dept. Women’s and Children’s Health, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470)
6 Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht, Oncode Institute, Hubrecht Institute, Utrecht, Netherlands (GRID:grid.418101.d) (ISNI:0000 0001 2153 6865)
7 Armenise/Harvard Laboratory of Integrative Genomics, Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy (GRID:grid.410439.b) (ISNI:0000 0004 1758 1171); Next Generation Diagnostic srl, Pozzuoli, Italy (GRID:grid.410439.b)
8 Queensland Children’s Hospital, Gastroenterology, Hepatology and Liver Transplant, Brisbane, Australia (GRID:grid.240562.7)
9 the Francis Crick Institute, Stem Cell and Cancer Biology Lab, London, UK (GRID:grid.451388.3) (ISNI:0000 0004 1795 1830)
10 Armenise/Harvard Laboratory of Integrative Genomics, Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy (GRID:grid.410439.b) (ISNI:0000 0004 1758 1171); University of Naples Federico II, Department of Translational Medicine, Naples, Italy (GRID:grid.4691.a) (ISNI:0000 0001 0790 385X)
11 Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht, Oncode Institute, Hubrecht Institute, Utrecht, Netherlands (GRID:grid.418101.d) (ISNI:0000 0001 2153 6865); Princess Máxima Center (PMC) for Pediatric Oncology, Utrecht, Netherlands (GRID:grid.487647.e)
12 GOS Institute of Child Health, University College London, Stem Cell and Regenerative Medicine Section, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); Veneto Institute of Molecular Medicine (VIMM), Padova, Italy (GRID:grid.428736.c); ShanghaiTech University, Shanghai Institute for Advanced Immunochemical Studies (SIAIS), Shanghai, China (GRID:grid.440637.2) (ISNI:0000 0004 4657 8879); University of Padova, Dept. of Industrial Engineering, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470)
13 GOS Institute of Child Health, University College London, Stem Cell and Regenerative Medicine Section, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); Great Ormond Street Hospital, Dept. of Specialist Neonatal and Paediatric Surgery, London, UK (GRID:grid.420468.c)